This site has not been optimised for Internet Explorer due to Microsoft no longer providing support for the browser. Please view this site using another browser such as Google Chrome or Microsoft Edge.
Te Pū rauemi KOWHEORI-19 COVID-19 resource hub

Support for people working in health during the COVID-19 pandemic. Find information about how you can support yourselves and others, including consumers, teams and colleagues which complements and aligns with Ministry of Health resources.

Kia āta kōwhiri Choosing Wisely

The Choosing Wisely campaign seeks to reduce harm from unnecessary and low-value tests and treatment.

Back to previous page

Presentations from the New Zealand workshop on Clostridium Difficile infection

19 Nov 2021

Presentations given by speakers at the New Zealand workshop on Clostridium Difficile infection (CDI). Links to the presentations can be found at the bottom of the page.

Clostridium difficile infection: the Australian experience 

Professor Tom Riley, Department of Microbiology, University of Western Australia

Topics discussed were the history and characteristics of the C difficile bacterium, risk factors for infection, emergence of hospital outbreaks and virulent strains in the US, UK, Europe and Australia, community-acquired CDI, virulent strains, potential animal and food sources of infection and CDI control strategies.

An Australian national approach to C difficile

Dr Marilyn Cruickshank, Program Director, Australian Commission on Safety and Quality in Health Care (ACSQHC)

Dr Cruickshank discussed the Australian health system’s organisation, performance and accountability frameworks and development of national monitoring and surveillance of CDI.  

Clostridium difficile infection: New Zealand perspective

Dr Sally Roberts, Infectious Diseases Physician and Clinical Microbiologist, Auckland DHB and HQSC

Dr Roberts reviewed the laboratory diagnosis of CDI in NZ, findings from two national surveys (2009 and 2011), the newly emergent Ribotype 244 in severe community onset CDI in New Zealand and Australia and the previously unrecognised issue of CDI in hospitalised children. She briefly discussed infection prevention and control and surveillance of CDI.

Clostridium difficile infection (CDI) – issues around surveillance and notifiability

Dr John Holmes, Public Health Medicine Specialist, ESR and University of Otago

Dr Holmes outlined the nature of surveillance and disease notification in New Zealand, describing the following options for surveillance of CDI: maintenance of status quo, formalisation of biennial voluntary surveillance, enhanced annual surveillance or laboratory notification.